Growth Metrics

Armata Pharmaceuticals (ARMP) Total Liabilities (2016 - 2026)

Quarterly results put Total Liabilities at $381.4 million for Q1 2026, up 170.42% from a year ago — trailing twelve months through Mar 2026 was $381.4 million (up 170.42% YoY), and the annual figure for FY2025 was $295.5 million, up 119.76%.

Armata Pharmaceuticals has reported Total Liabilities over the past 14 years, most recently at $381.4 million for Q1 2026.

  • Total Liabilities reached $381.4 million in Q1 2026 per ARMP's latest filing, up from $295.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $381.4 million in Q1 2026 and bottomed at $46.2 million in Q1 2022.
  • Median Total Liabilities over the past 5 years was $134.5 million (2024), compared with a mean of $140.8 million.
  • The largest annual shift saw Total Liabilities decreased 20.26% in 2025 before it surged 170.42% in 2026.
  • Over 5 years, Total Liabilities stood at $59.8 million in 2022, then soared by 118.27% to $130.4 million in 2023, then increased by 3.09% to $134.5 million in 2024, then skyrocketed by 119.76% to $295.5 million in 2025, then rose by 29.07% to $381.4 million in 2026.
  • Business Quant data shows Total Liabilities for ARMP at $381.4 million in Q1 2026, $295.5 million in Q4 2025, and $185.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 16.35 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.74 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 177.22 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 7.12 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 9.45 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 10.44 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.05 Bn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - 381.39 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 381.39 Mn
Dec 31, 2025 295.48 Mn
Sep 30, 2025 185.10 Mn
Jun 30, 2025 150.29 Mn
Mar 31, 2025 141.03 Mn
Dec 31, 2024 134.46 Mn
Sep 30, 2024 149.21 Mn
Jun 30, 2024 154.41 Mn
Mar 31, 2024 176.87 Mn
Dec 31, 2023 130.43 Mn
Sep 30, 2023 125.15 Mn
Jun 30, 2023 82.07 Mn
Mar 31, 2023 86.33 Mn
Dec 31, 2022 59.75 Mn
Sep 30, 2022 47.30 Mn
Jun 30, 2022 47.69 Mn
Mar 31, 2022 46.23 Mn
Dec 31, 2021 44.37 Mn
Sep 30, 2021 18.92 Mn
Jun 30, 2021 19.66 Mn
Mar 31, 2021 18.83 Mn
Dec 31, 2020 20.66 Mn
Sep 30, 2020 21.06 Mn
Jun 30, 2020 19.82 Mn
Mar 31, 2020 10.62 Mn
Dec 31, 2019 10.86 Mn
Sep 30, 2019 11.17 Mn
Jun 30, 2019 12.29 Mn
Mar 31, 2019 4.66 Mn
Dec 31, 2018 6.85 Mn
Sep 30, 2018 3.77 Mn
Jun 30, 2018 3.38 Mn
Mar 31, 2018 3.11 Mn
Dec 31, 2017 3.41 Mn
Sep 30, 2017 4.02 Mn
Jun 30, 2017 5.25 Mn
Mar 31, 2017 7.65 Mn
Dec 31, 2016 8.43 Mn
Sep 30, 2016 7.81 Mn
Jun 30, 2016 7.80 Mn